|Study Name||Study Title||Status||Recruit.||Contact|
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy and safety of pazopanib as a...
Multicenter, phase III, randomized study to evaluate treatment customized according to RAP80 and BRCA1 assessment in...
Randomized Phase 3 Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subj...
Role of cancer stem cells in brain tumor initiation and progression
A non - interventional study to follow and evaluate patients with advanced NSCLC who are treated in a second line se...
This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.